PUBLISHER: Grand View Research | PRODUCT CODE: 1750875
PUBLISHER: Grand View Research | PRODUCT CODE: 1750875
The global bacterial and viral specimen collection market size is anticipated to reach USD 33.37 billion by 2030 and expand at a CAGR of 14.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing burden of infectious diseases such as COVID-19, influenza, and tuberculosis has significantly increased the demand for bacterial and viral specimen collection. As healthcare systems strive to contain outbreaks and improve patient outcomes, governments and private sectors are ramping up healthcare investments. This surge in healthcare spending supports expanded diagnostic testing, better infrastructure, and the development of efficient specimen collection tools, ultimately driving market growth.
Technological advancements in diagnostics, including PCR, molecular assays, and rapid test platforms, have revolutionized the way infections are detected. These innovations require reliable and high-quality specimen collection methods to ensure accuracy. In addition, rising awareness among healthcare providers and patients about the importance of early and precise diagnosis increases testing volumes, thereby fueling demand for advanced specimen collection tools and boosting the overall market size.
The shift toward decentralized healthcare, driven by the convenience and accessibility of home testing and point-of-care diagnostics, is reshaping the specimen collection landscape. These trends reduce reliance on traditional lab settings and increase sample collection frequency. In addition, expanding research and clinical trials for vaccines, therapeutics, and infectious disease surveillance are boosting demand for standardized specimen collection kits, contributing significantly to the market's growth and broadening its application across various sectors.